Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI - STAT

Federal regulators are meeting with companies and researchers to develop rules for AI used in healthcare and medical decisions. These rules could affect how AI is deployed in hospitals and clinics that treat patients.